Clinical Trials Evaluating the Role of Sentinel Node Resection (SNR) in Early-Stage Breast Cancer

CME test	Downloadable PDF	PowerPoint slides	CME Information and Faculty Disclosures
Read Dr Love's original email (from July 20, 2010)			Subscribe to Dr Love's email alerts

Slides from presentations at ASCO 2010 and transcribed comments from recent interviews with Kathy D Miller, MD (6/11/10) and Eric P Winer, MD (7/6/10)

 

Krag DN et al. Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients. Proc ASCO 2010;Abstract LBA505.

Cote R et al. ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. Proc ASCO 2010;Abstract CRA504.

Guiliano AE et al. ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. Proc ASCO 2010;Abstract CRA506.

Go to previous Journal Club